Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| THERMO FISHER SCIENTIFIC INC.TMO · Entity 2836 | Executive Vice President | February 28, 2026 | March 02, 2026 |
| VERTEX PHARMACEUTICALS INC / MAVRTX · Entity 2875 | Director | May 01, 2026 | May 05, 2026 |
| WEST PHARMACEUTICAL SERVICES INCWST · Entity 3201 | Director · President and CEO | September 08, 2026 | September 10, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
THERMO FISHER SCIENTIFIC INC.
Report date February 28, 2026 · Filed March 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 85,151.304 |
Ending reported balance
After 2026-02-28 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-02-28 · Tax withholding · Disposed 836.88 · Balance 85,511.029 Row 2 · 2026-02-28 · Tax withholding · Disposed 359.725 · Balance 85,151.304 |
VERTEX PHARMACEUTICALS INC / MA
Report date May 01, 2026 · Filed May 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $424.45 · Expires 2036-04-30 | Direct | 2,866 |
Reported balance
After 2026-05-01 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-05-01 · Grant · Acquired 2,866 · Balance 2,866 F1: Fully vested. |
Filing footnotes · ownership attribution and instrument terms
F1: Fully vested.
WEST PHARMACEUTICAL SERVICES INC
Report date September 08, 2026 · Filed September 10, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $337.75 · Expires 2036-09-08 | Direct | 13,879 |
Reported balance
After 2026-09-08 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-09-08 · Grant · Acquired 13,879 · Balance 13,879 F1: This award vests in four equal annual installments beginning on September 8, 2027. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $337.75 · Expires 2036-09-08 | Direct | 11,081 |
Reported balance
After 2026-09-08 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-09-08 · Grant · Acquired 11,081 · Balance 11,081 F1: This award vests in four equal annual installments beginning on September 8, 2027. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $337.75 · Expires 2036-09-08 | Direct | 12,088 |
Reported balance
After 2026-09-08 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-09-08 · Grant · Acquired 12,088 · Balance 12,088 F2: This award cliff vests on September 8, 2031. |
| Rst. Stock UnitSEC Table II · derivative / convertible security | Direct | 6,200 |
Reported balance
After 2026-09-08 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-09-08 · Grant · Acquired 6,200 · Balance 6,200 F3: Each restricted stock unit represents a contingent right to receive one share of WST common stock. F1: This award vests in four equal annual installments beginning on September 8, 2027. |
| Rst. Stock UnitSEC Table II · derivative / convertible security | Direct | 4,950 |
Reported balance
After 2026-09-08 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-09-08 · Grant · Acquired 4,950 · Balance 4,950 F3: Each restricted stock unit represents a contingent right to receive one share of WST common stock. F1: This award vests in four equal annual installments beginning on September 8, 2027. |
| Rst. Stock UnitSEC Table II · derivative / convertible security | Direct | 3,600 |
Reported balance
After 2026-09-08 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-09-08 · Grant · Acquired 3,600 · Balance 3,600 F3: Each restricted stock unit represents a contingent right to receive one share of WST common stock. F2: This award cliff vests on September 8, 2031. |
Filing footnotes · ownership attribution and instrument terms
F1: This award vests in four equal annual installments beginning on September 8, 2027.
F2: This award cliff vests on September 8, 2031.
F3: Each restricted stock unit represents a contingent right to receive one share of WST common stock.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Patheon N.V.
Report date August 29, 2017 · Filed August 31, 2017
Section 16 reporting ended · disclosed 2017-08-31. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2017-08-29 transaction · row 1
1 source rowRow 1 · 2017-08-29 · Other · Disposed 245,939 · Balance 0 F1: Ordinary shares of Patheon N.V. ("Issuer") were disposed of pursuant to a tender offer by Thermo Fisher (CN) Luxembourg S.a r.l., a private limited liability company (societe a responsabilite limitee) organized under the laws of the Grand Duchy of Luxembourg ("Purchaser") and Thermo Fisher Scientific Inc., a Delaware corporation ("Thermo Fisher"), to acquire all of the issued and outstanding ordinary shares (the "Shares") of Issuer at a purchase price of $35.00 per Share, pursuant to the terms of the Purchase Agreement, dated as of May 15, 2017 (as it may be amended from time to time, the "Purchase Agreement"), by and between Issuer, Purchaser and Thermo Fisher. Pursuant to the terms of the Purchase Agreement, each vested restricted stock unit was cancelled and converted into the right to receive an amount in cash, without interest, equal to the product obtained by multiplying $35.00 by the total number of Shares subject to the restricted stock unit (continued in footnote 2) F2: upon the closing of the tender offer (with restricted stock units that are subject to performance conditions vesting based on achievement of actual performance conditions in accordance with the terms of the award). Each unvested restricted stock unit was cancelled and converted into a restricted stock unit award, with substantially the same terms and conditions (including with respect to vesting) as were applicable to such unvested restricted stock unit immediately prior to the closing of the tender offer, with respect to a number of shares of Thermo Fisher common stock equal to the product (rounded to the nearest whole share) obtained by multiplying (x) the Exchange Ratio by (y) the total number of Shares subject to the unvested restricted stock unit as of immediately prior to the closing of the tender offer. (continued in footnote 3) F3: The "Exchange Ratio" is 0.1996919, which represents the quotient obtained by dividing (i) $35.00 by (ii) the average closing price, rounded to the nearest cent, per share of common stock of Thermo Fisher on the NYSE for the consecutive period of ten (10) trading days immediately preceding (but not including) the date of the closing of the tender offer. F4: This amount includes 201,199 unvested restricted stock units, each of which represented a contingent right to receive one Share of Issuer. Each unvested restricted stock unit was cancelled and converted into a restricted stock unit award, with substantially the same terms and conditions (including with respect to vesting) as were applicable to such unvested restricted stock unit immediately prior to the closing of the tender offer, with respect to a number of shares of Thermo Fisher common stock equal to the product (rounded to the nearest whole share) obtained by multiplying (x) the Exchange Ratio by (y) the total number of Shares subject to the unvested restricted stock unit as of immediately prior to the closing of the tender offer. |
| Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $26.49 | Direct | 0 |
Reported balance
After 2017-08-29 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2017-08-29 · Disposition to issuer · Disposed 110,402 · Balance 0 F5: The terms of the Option awards provide that options vest in three equal installments on each anniversary of the grant date of March 23, 2017. Options were disposed of pursuant to the Purchase Agreement, whereby each vested option was cancelled and converted into the right to receive an amount in cash, without interest, equal to the product of (x) the excess of $35.00 over the per Share exercise price of the option, multiplied by the number of Shares subject to the option upon the closing of the tender offer (rounded down to the nearest whole share). Each unvested option was cancelled and converted into a stock option award, with substantially the same terms and conditions (including with respect to vesting) as were applicable to such unvested option immediately prior to the closing of the tender offer, (i) with respect to a number of shares of Thermo Fisher common stock equal to the product (rounded down to the nearest whole share) obtained by multiplying (x) (continued in footnote 6) F6: the Exchange Ratio by (y) the total number of Shares subject to such unvested option as of immediately prior to the closing of the tender offer and (ii) at an exercise price per share that is equal to the quotient (rounded up to the nearest cent) obtained by dividing (x) the exercise price per share of such unvested option by (y) the Exchange Ratio. |
Filing footnotes · ownership attribution and instrument terms
F1: Ordinary shares of Patheon N.V. ("Issuer") were disposed of pursuant to a tender offer by Thermo Fisher (CN) Luxembourg S.a r.l., a private limited liability company (societe a responsabilite limitee) organized under the laws of the Grand Duchy of Luxembourg ("Purchaser") and Thermo Fisher Scientific Inc., a Delaware corporation ("Thermo Fisher"), to acquire all of the issued and outstanding ordinary shares (the "Shares") of Issuer at a purchase price of $35.00 per Share, pursuant to the terms of the Purchase Agreement, dated as of May 15, 2017 (as it may be amended from time to time, the "Purchase Agreement"), by and between Issuer, Purchaser and Thermo Fisher. Pursuant to the terms of the Purchase Agreement, each vested restricted stock unit was cancelled and converted into the right to receive an amount in cash, without interest, equal to the product obtained by multiplying $35.00 by the total number of Shares subject to the restricted stock unit (continued in footnote 2)
F2: upon the closing of the tender offer (with restricted stock units that are subject to performance conditions vesting based on achievement of actual performance conditions in accordance with the terms of the award). Each unvested restricted stock unit was cancelled and converted into a restricted stock unit award, with substantially the same terms and conditions (including with respect to vesting) as were applicable to such unvested restricted stock unit immediately prior to the closing of the tender offer, with respect to a number of shares of Thermo Fisher common stock equal to the product (rounded to the nearest whole share) obtained by multiplying (x) the Exchange Ratio by (y) the total number of Shares subject to the unvested restricted stock unit as of immediately prior to the closing of the tender offer. (continued in footnote 3)
F3: The "Exchange Ratio" is 0.1996919, which represents the quotient obtained by dividing (i) $35.00 by (ii) the average closing price, rounded to the nearest cent, per share of common stock of Thermo Fisher on the NYSE for the consecutive period of ten (10) trading days immediately preceding (but not including) the date of the closing of the tender offer.
F4: This amount includes 201,199 unvested restricted stock units, each of which represented a contingent right to receive one Share of Issuer. Each unvested restricted stock unit was cancelled and converted into a restricted stock unit award, with substantially the same terms and conditions (including with respect to vesting) as were applicable to such unvested restricted stock unit immediately prior to the closing of the tender offer, with respect to a number of shares of Thermo Fisher common stock equal to the product (rounded to the nearest whole share) obtained by multiplying (x) the Exchange Ratio by (y) the total number of Shares subject to the unvested restricted stock unit as of immediately prior to the closing of the tender offer.
F5: The terms of the Option awards provide that options vest in three equal installments on each anniversary of the grant date of March 23, 2017. Options were disposed of pursuant to the Purchase Agreement, whereby each vested option was cancelled and converted into the right to receive an amount in cash, without interest, equal to the product of (x) the excess of $35.00 over the per Share exercise price of the option, multiplied by the number of Shares subject to the option upon the closing of the tender offer (rounded down to the nearest whole share). Each unvested option was cancelled and converted into a stock option award, with substantially the same terms and conditions (including with respect to vesting) as were applicable to such unvested option immediately prior to the closing of the tender offer, (i) with respect to a number of shares of Thermo Fisher common stock equal to the product (rounded down to the nearest whole share) obtained by multiplying (x) (continued in footnote 6)
F6: the Exchange Ratio by (y) the total number of Shares subject to such unvested option as of immediately prior to the closing of the tender offer and (ii) at an exercise price per share that is equal to the quotient (rounded up to the nearest cent) obtained by dividing (x) the exercise price per share of such unvested option by (y) the Exchange Ratio.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 01, 2022 Filed Mar 2, 2022 21:17 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | SaleCommon Stock | 1,000 | $541.52 | $541,515.00 |
DisclosureSEC source: 0001127602-22-007673 · form4.xml · nonDerivative · entry 2 Lagarde Michel · CIK 0001518973 · Executive Vice President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,878.205 Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 21:17 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | SaleCommon Stock | 5,100 | $541.25 | $2,760,375.00 |
DisclosureSEC source: 0001127602-22-007673 · form4.xml · nonDerivative · entry 1 Lagarde Michel · CIK 0001518973 · Executive Vice President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,878.205 Read SEC document |
| February 25, 2022 Filed Mar 2, 2022 00:24 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Tax withholdingCommon Stock | 1,025 | $549.83 | $563,575.75 |
DisclosureSEC source: 0001127602-22-007459 · form4.xml · nonDerivative · entry 1 Lagarde Michel · CIK 0001518973 · Executive Vice President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,978.205 Read SEC document |
| February 23, 2022 Filed Feb 25, 2022 22:25 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | GrantStock Option (Right to Buy) · Derivative | 13,941 | $0.00 Strike: $528.58 | $0.00 |
DisclosureSEC source: 0001127602-22-006851 · form4.xml · derivative · entry 5 Lagarde Michel · CIK 0001518973 · Executive Vice President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,941 Underlying: Common Stock · 13,941 shares Expires 2030-02-23 F2 · derivative.exercise_date: The option vests in four equal annual installments beginning on February 28, 2023. Read SEC document |
| February 23, 2022 Filed Feb 25, 2022 22:25 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Tax withholdingCommon Stock | 864 | $528.58 | $456,693.12 |
DisclosureSEC source: 0001127602-22-006851 · form4.xml · nonDerivative · entry 4 Lagarde Michel · CIK 0001518973 · Executive Vice President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,003.205 Read SEC document |
| February 23, 2022 Filed Feb 25, 2022 22:25 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | GrantCommon Stock | 1,806 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-006851 · form4.xml · nonDerivative · entry 3 Lagarde Michel · CIK 0001518973 · Executive Vice President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,867.205 Read SEC document |
| February 23, 2022 Filed Feb 25, 2022 22:25 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Tax withholdingCommon Stock | 899 | $528.58 | $475,193.42 |
DisclosureSEC source: 0001127602-22-006851 · form4.xml · nonDerivative · entry 2 Lagarde Michel · CIK 0001518973 · Executive Vice President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,061.205 Read SEC document |
| February 23, 2022 Filed Feb 25, 2022 22:25 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | GrantCommon Stock | 6,081 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-006851 · form4.xml · nonDerivative · entry 1 Lagarde Michel · CIK 0001518973 · Executive Vice President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,960.205 F1 · shares: Shares represent a performance-based restricted stock unit award granted on February 23, 2021. The Company's Compensation Committee determined on February 23, 2022, that the performance criteria related to this award were satisfied. One-third of the shares vested on February 23, 2022, and one-third of the shares vest on February 23, 2023. The remaining one-third will vest on February 23, 2024, and is subject to adjustment (positive or negative) for long-term performance which is based on the comparison of the Company's total shareholder return compound annual growth rate ("CAGR") to the total shareholder return CAGR of each of the companies in the peer group, as specified within the award agreement, over the measurement period starting on January 1, 2021, through to December 31, 2023. Read SEC document |
| November 01, 2021 Filed Nov 3, 2021 20:35 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | GrantStock Option (Right to Buy) · Derivative | 13,366 | $0.00 Strike: $635.10 | $0.00 |
DisclosureSEC source: 0001127602-21-028294 · form4.xml · derivative · entry 1 Lagarde Michel · CIK 0001518973 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,366 Underlying: Common Stock · 13,366 shares Expires 2028-11-01 F1 · derivative.exercise_date: The option vests in four equal annual installments beginning on November 1, 2022. Read SEC document |
| August 27, 2021 Filed Aug 30, 2021 20:11 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Tax withholdingCommon Stock | 293 | $548.51 | $160,713.43 |
DisclosureSEC source: 0001127602-21-024533 · form4.xml · nonDerivative · entry 2 Lagarde Michel · CIK 0001518973 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,879.205 Read SEC document |
| August 26, 2021 Filed Aug 30, 2021 20:11 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Tax withholdingCommon Stock | 566 | $552.77 | $312,867.82 |
DisclosureSEC source: 0001127602-21-024533 · form4.xml · nonDerivative · entry 1 Lagarde Michel · CIK 0001518973 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,172.205 Read SEC document |
| August 25, 2021 Filed Aug 26, 2021 20:14 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Tax withholdingCommon Stock | 491 | $548.08 | $269,107.28 |
DisclosureSEC source: 0001127602-21-024347 · form4.xml · nonDerivative · entry 1 Lagarde Michel · CIK 0001518973 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,738.205 Read SEC document |
| August 23, 2021 Filed Aug 24, 2021 20:06 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Tax withholdingCommon Stock | 232 | $552.61 | $128,205.52 |
DisclosureSEC source: 0001127602-21-024218 · form4.xml · nonDerivative · entry 1 Lagarde Michel · CIK 0001518973 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,229.205 Read SEC document |
| May 10, 2021 Filed May 11, 2021 20:44 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Exercise / conversionStock Option (Right to Buy) · Derivative | 21,600 | $0.00 Strike: $190.59 | $0.00 |
DisclosureSEC source: 0001127602-21-016241 · form4.xml · derivative · entry 20 Lagarde Michel · CIK 0001518973 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,900 Underlying: Common Stock · 21,600 shares Expires 2024-09-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F17 · derivative.exercise_date: The option vests in four equal annual installments. One-quarter of the shares vested on September 7, 2018, 2019 and 2020, and the remaining one-quarter will vest on September 7, 2021. Read SEC document |
| May 10, 2021 Filed May 11, 2021 20:44 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | SaleCommon Stock | 453 | $467.16 | $211,623.48 |
DisclosureSEC source: 0001127602-21-016241 · form4.xml · nonDerivative · entry 18 Lagarde Michel · CIK 0001518973 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,461.205 F16 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $466.99 to $467.37, inclusive. Read SEC document |
| May 10, 2021 Filed May 11, 2021 20:44 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | SaleCommon Stock | 5,103 | $466.03 | $2,378,151.09 |
DisclosureSEC source: 0001127602-21-016241 · form4.xml · nonDerivative · entry 17 Lagarde Michel · CIK 0001518973 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,914.205 F15 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $465.59 to $466.54, inclusive. Read SEC document |
| May 10, 2021 Filed May 11, 2021 20:44 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | SaleCommon Stock | 5,051 | $465.07 | $2,349,068.57 |
DisclosureSEC source: 0001127602-21-016241 · form4.xml · nonDerivative · entry 16 Lagarde Michel · CIK 0001518973 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,017.205 F14 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $464.59 to $465.54, inclusive. Read SEC document |
| May 10, 2021 Filed May 11, 2021 20:44 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | SaleCommon Stock | 3,734 | $463.85 | $1,732,015.90 |
DisclosureSEC source: 0001127602-21-016241 · form4.xml · nonDerivative · entry 15 Lagarde Michel · CIK 0001518973 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,068.205 F13 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $463.57 to $464.52, inclusive. Read SEC document |
| May 10, 2021 Filed May 11, 2021 20:44 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | SaleCommon Stock | 7,259 | $463.24 | $3,362,659.16 |
DisclosureSEC source: 0001127602-21-016241 · form4.xml · nonDerivative · entry 14 Lagarde Michel · CIK 0001518973 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,802.205 F12 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $462.57 to $463.56, inclusive. Read SEC document |
| May 10, 2021 Filed May 11, 2021 20:44 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Exercise / conversionCommon Stock | 21,600 | $190.59 | $4,116,744.00 |
DisclosureSEC source: 0001127602-21-016241 · form4.xml · nonDerivative · entry 13 Lagarde Michel · CIK 0001518973 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,061.205 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 07, 2021 Filed May 11, 2021 20:44 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Exercise / conversionStock Option (Right to Buy) · Derivative | 29,100 | $0.00 Strike: $190.59 | $0.00 |
DisclosureSEC source: 0001127602-21-016241 · form4.xml · derivative · entry 19 Lagarde Michel · CIK 0001518973 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 29,100 shares Expires 2024-09-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 07, 2021 Filed May 11, 2021 20:44 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | SaleCommon Stock | 134 | $478.78 | $64,156.52 |
DisclosureSEC source: 0001127602-21-016241 · form4.xml · nonDerivative · entry 12 Lagarde Michel · CIK 0001518973 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,461.205 F11 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $478.56 to $478.85, inclusive. Read SEC document |
| May 07, 2021 Filed May 11, 2021 20:44 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | SaleCommon Stock | 4,162 | $478.02 | $1,989,519.24 |
DisclosureSEC source: 0001127602-21-016241 · form4.xml · nonDerivative · entry 11 Lagarde Michel · CIK 0001518973 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,595.205 F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $477.56 to $478.55, inclusive. Read SEC document |
| May 07, 2021 Filed May 11, 2021 20:44 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | SaleCommon Stock | 1,268 | $476.80 | $604,582.40 |
DisclosureSEC source: 0001127602-21-016241 · form4.xml · nonDerivative · entry 10 Lagarde Michel · CIK 0001518973 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,757.205 F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $476.43 to $477.37, inclusive. Read SEC document |
| May 07, 2021 Filed May 11, 2021 20:44 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | SaleCommon Stock | 3,802 | $475.96 | $1,809,599.92 |
DisclosureSEC source: 0001127602-21-016241 · form4.xml · nonDerivative · entry 9 Lagarde Michel · CIK 0001518973 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,025.205 F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $475.38 to $476.37, inclusive. Read SEC document |
| May 07, 2021 Filed May 11, 2021 20:44 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | SaleCommon Stock | 3,424 | $475.02 | $1,626,468.48 |
DisclosureSEC source: 0001127602-21-016241 · form4.xml · nonDerivative · entry 8 Lagarde Michel · CIK 0001518973 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,827.205 F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $474.38 to $475.37, inclusive. Read SEC document |
| May 07, 2021 Filed May 11, 2021 20:44 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | SaleCommon Stock | 2,578 | $474.00 | $1,221,972.00 |
DisclosureSEC source: 0001127602-21-016241 · form4.xml · nonDerivative · entry 7 Lagarde Michel · CIK 0001518973 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,251.205 F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $473.35 to $474.33, inclusive. Read SEC document |
| May 07, 2021 Filed May 11, 2021 20:44 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | SaleCommon Stock | 1,523 | $472.79 | $720,059.17 |
DisclosureSEC source: 0001127602-21-016241 · form4.xml · nonDerivative · entry 6 Lagarde Michel · CIK 0001518973 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,829.205 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $472.305 to $473.06, inclusive. Read SEC document |
| May 07, 2021 Filed May 11, 2021 20:44 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | SaleCommon Stock | 1,100 | $471.80 | $518,980.00 |
DisclosureSEC source: 0001127602-21-016241 · form4.xml · nonDerivative · entry 5 Lagarde Michel · CIK 0001518973 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,352.205 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $471.14 to $472.015, inclusive. Read SEC document |
| May 07, 2021 Filed May 11, 2021 20:44 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | SaleCommon Stock | 2,949 | $470.47 | $1,387,416.03 |
DisclosureSEC source: 0001127602-21-016241 · form4.xml · nonDerivative · entry 4 Lagarde Michel · CIK 0001518973 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,452.205 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $470.11 to $470.96, inclusive. Read SEC document |
| May 07, 2021 Filed May 11, 2021 20:44 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | SaleCommon Stock | 5,566 | $469.57 | $2,613,626.62 |
DisclosureSEC source: 0001127602-21-016241 · form4.xml · nonDerivative · entry 3 Lagarde Michel · CIK 0001518973 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,401.205 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $469.08 to $470.05, inclusive. Read SEC document |
| May 07, 2021 Filed May 11, 2021 20:44 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | SaleCommon Stock | 7,662 | $468.71 | $3,591,256.02 |
DisclosureSEC source: 0001127602-21-016241 · form4.xml · nonDerivative · entry 2 Lagarde Michel · CIK 0001518973 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,967.205 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $468.08 to $469.07, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4), (5), (6), (7), (8), (9), (10), (11), (12), (13), (14), (15), and (16) to this Form 4. Read SEC document |
| May 07, 2021 Filed May 11, 2021 20:44 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Exercise / conversionCommon Stock | 29,100 | $190.59 | $5,546,169.00 |
DisclosureSEC source: 0001127602-21-016241 · form4.xml · nonDerivative · entry 1 Lagarde Michel · CIK 0001518973 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,629.205 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 07, 2021 Filed Mar 8, 2021 21:10 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Tax withholdingCommon Stock | 945 | $446.87 | $422,292.15 |
DisclosureSEC source: 0001127602-21-009666 · form4.xml · nonDerivative · entry 2 Lagarde Michel · CIK 0001518973 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,529.205 Read SEC document |
| March 05, 2021 Filed Mar 8, 2021 21:10 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Tax withholdingCommon Stock | 100 | $446.87 | $44,687.00 |
DisclosureSEC source: 0001127602-21-009666 · form4.xml · nonDerivative · entry 1 Lagarde Michel · CIK 0001518973 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,474.205 Read SEC document |
| February 26, 2021 Filed Mar 1, 2021 21:21 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Tax withholdingCommon Stock | 570 | $450.08 | $256,545.60 |
DisclosureSEC source: 0001127602-21-008332 · form4.xml · nonDerivative · entry 2 Lagarde Michel · CIK 0001518973 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,574.205 Read SEC document |
| February 25, 2021 Filed Mar 1, 2021 21:21 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Tax withholdingCommon Stock | 1,025 | $451.47 | $462,756.75 |
DisclosureSEC source: 0001127602-21-008332 · form4.xml · nonDerivative · entry 1 Lagarde Michel · CIK 0001518973 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,144.205 Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 22:29 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | GrantStock Option (Right to Buy) · Derivative | 15,575 | $0.00 Strike: $458.81 | $0.00 |
DisclosureSEC source: 0001127602-21-007945 · form4.xml · derivative · entry 5 Lagarde Michel · CIK 0001518973 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,575 Underlying: Common Stock · 15,575 shares Expires 2028-02-23 F3 · derivative.exercise_date: The option vests in four equal annual installments beginning on February 23, 2022. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 22:29 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | GrantStock Option (Right to Buy) · Derivative | 29,100 | $0.00 Strike: $190.59 | $0.00 |
DisclosureSEC source: 0001127602-21-007945 · form4.xml · derivative · entry 4 Lagarde Michel · CIK 0001518973 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,100 Underlying: Common Stock · 29,100 shares Expires 2024-09-07 F2 · shares: This performance-based stock option award was granted on September 7, 2017. The Company's Compensation Committee certified on February 23, 2021 that the performance criteria related to this award were satisfied. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 22:29 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | GrantCommon Stock | 3,475 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-007945 · form4.xml · nonDerivative · entry 3 Lagarde Michel · CIK 0001518973 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,169.205 Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 22:29 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Tax withholdingCommon Stock | 825 | $458.81 | $378,518.25 |
DisclosureSEC source: 0001127602-21-007945 · form4.xml · nonDerivative · entry 2 Lagarde Michel · CIK 0001518973 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,694.205 Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 22:29 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | GrantCommon Stock | 7,744 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-007945 · form4.xml · nonDerivative · entry 1 Lagarde Michel · CIK 0001518973 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,519.205 F1 · shares: Shares represent a performance-based restricted stock unit award granted on February 25, 2020. The Company's Compensation Committee determined on February 23, 2021, that the performance criteria related to this award were satisfied. One-third of the shares vested on February 23, 2021, one-third of the shares vest on February 23, 2022, and the remaining one-third vest on February 23, 2023. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 21:01 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | SaleCommon Stock | 7,290 | $507.79 | $3,701,789.10 |
DisclosureSEC source: 0001127602-21-006138 · form4.xml · nonDerivative · entry 1 Lagarde Michel · CIK 0001518973 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,775.205 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $507.725 to $508.11, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 27, 2020 Filed Aug 31, 2020 20:42 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Tax withholdingCommon Stock | 293 | $420.53 | $123,215.29 |
DisclosureSEC source: 0001127602-20-024471 · form4.xml · nonDerivative · entry 1 Lagarde Michel · CIK 0001518973 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,065.205 Read SEC document |
| August 26, 2020 Filed Aug 27, 2020 20:19 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Tax withholdingCommon Stock | 471 | $425.65 | $200,481.15 |
DisclosureSEC source: 0001127602-20-024320 · form4.xml · nonDerivative · entry 2 Lagarde Michel · CIK 0001518973 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,358.205 Read SEC document |
| August 25, 2020 Filed Aug 27, 2020 20:19 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Tax withholdingCommon Stock | 295 | $422.29 | $124,575.55 |
DisclosureSEC source: 0001127602-20-024320 · form4.xml · nonDerivative · entry 1 Lagarde Michel · CIK 0001518973 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,829.205 Read SEC document |
| March 23, 2020 Filed Mar 24, 2020 21:09 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Tax withholdingCommon Stock | 1,256 | $278.37 | $349,632.72 |
DisclosureSEC source: 0001127602-20-011862 · form4.xml · nonDerivative · entry 1 Lagarde Michel · CIK 0001518973 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,124.205 Read SEC document |
| March 07, 2020 Filed Mar 9, 2020 20:26 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Tax withholdingCommon Stock | 945 | $311.17 | $294,055.65 |
DisclosureSEC source: 0001127602-20-009963 · form4.xml · nonDerivative · entry 2 Lagarde Michel · CIK 0001518973 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,380.205 Read SEC document |
| March 05, 2020 Filed Mar 9, 2020 20:26 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Tax withholdingCommon Stock | 60 | $312.89 | $18,773.40 |
DisclosureSEC source: 0001127602-20-009963 · form4.xml · nonDerivative · entry 1 Lagarde Michel · CIK 0001518973 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,325.205 Read SEC document |
| March 04, 2020 Filed Mar 5, 2020 21:28 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | SaleCommon Stock | 12,000 | $318.54 | $3,822,480.00 |
DisclosureSEC source: 0001127602-20-009624 · form4.xml · nonDerivative · entry 2 Lagarde Michel · CIK 0001518973 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,385.205 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 3, 2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.